Emerging Cryptos to Buy: Qubetics Presale Nears 10% Price Increase, Injective Launches AI-Powered iAgent 2.0, and Gala Expands Web3 Gaming and Entertainment

1 week ago 19

Ever wondered which cryptocurrencies are set to shake up the game in 2025? Injective’s groundbreaking iAgent 2.0 launch is revolutionizing AI-agent development, while Gala’s expansion into gaming and entertainment solidifies its status as a heavyweight in Web3 innovation. But while these projects are dominating their niches, Qubetics ($TICS) is solving a deeper issue—blockchain fragmentation.

Qubetics is rewriting the rulebook as the world’s first Web3 aggregator, bridging isolated blockchains like Ethereum and Solana to enable seamless data sharing and cross-chain transactions. Its presale is already making waves, raising over $10.4 million and setting the stage for explosive returns, with a 10% price increase just days away. If you’re looking for emerging cryptos to buy with real-world utility and massive growth potential, Qubetics is an obvious choice. Let’s break down why these three projects deserve your attention.

Qubetics Brings Blockchains Together

In the fragmented world of blockchain, interoperability remains a major roadblock. Qubetics ($TICS) tackles this head-on by acting as a Web3 aggregator that connects leading blockchains, making seamless cross-chain transactions and data sharing a reality. By eliminating barriers, Qubetics unlocks the full potential of blockchain technology for businesses, developers, and everyday users.

Picture a logistics company that needs to track shipments across different platforms. With Qubetics, the process becomes streamlined as data flows freely between blockchains like Ethereum and Solana. For small businesses handling multi-chain transactions, Qubetics eliminates the headache of juggling multiple wallets and protocols.

Even developers reap huge benefits. With Qubetics, they can build dApps that operate across networks without the usual complexity of cross-chain integration. Whether you’re a business looking to simplify operations or a coder aiming to innovate, Qubetics is redefining how blockchain ecosystems interact.

Qubetics Presale Takes the Spotlight

If you’re searching for emerging cryptos to buy, the best crypto presale is hard to ignore. Now in its 18th stage, this presale has raised over $10.4 million, welcomed more than 15,700 token holders, and sold an impressive 435 million $TICS tokens. The current price is $0.0551, but each stage lasts just seven days, with a 10% price hike every Sunday at midnight—and the next increase is just around the corner.

The ROI potential is nothing short of extraordinary. Analysts predict $TICS could hit $0.25 by the presale’s end, delivering a 353.39% ROI. If it climbs to $10 post-mainnet launch, the ROI skyrockets to 18,035.76%. Let’s crunch the numbers—a $1,000 investment today gets you 18,144 $TICS tokens. If the price reaches $10, that $1,000 turns into an astounding $181,440. With such eye-popping figures, it’s no surprise Qubetics is dominating the list of emerging cryptos to buy.

Injective Revolutionizes AI Development

Injective is making headlines with the launch of iAgent 2.0, a cutting-edge platform aimed at simplifying AI-agent development. This innovation allows developers to create autonomous agents for applications in finance, healthcare, and gaming, unlocking new possibilities in decentralized AI. iAgent 2.0 also integrates seamlessly with Injective’s Layer 1 blockchain, ensuring scalability and low transaction costs.

The platform has already gained traction, with over 1,000 developers participating in its pilot program. Injective has allocated significant resources to fund AI-agent projects, signaling its commitment to fostering innovation in this emerging field. The initiative also aligns with the growing demand for AI solutions that operate in decentralized ecosystems.

With its focus on bridging blockchain and AI, Injective is setting itself apart as a pioneer in this space. By offering tools that empower developers to build practical applications, Injective is not just innovating—it’s laying the groundwork for the future of decentralized AI.

Gala Expands Its Web3 Empire

Gala continues to dominate the Web3 space with its latest announcement to expand into new gaming and entertainment partnerships. Gala Games has revealed plans to integrate with leading entertainment platforms, aiming to bridge the gap between blockchain technology and mainstream audiences. The company’s ecosystem now supports over 28 games and has partnered with major studios to produce blockchain-based titles.

Gala’s foray into music and film also showcases its ambition to create a fully integrated entertainment ecosystem. Recent data shows a 35% increase in user activity within the Gala ecosystem, highlighting the growing demand for its services. Additionally, Gala’s tokenomics have been fine-tuned to reward active users, fostering community engagement and loyalty.

With its multi-pronged approach to gaming, music, and film, Gala is proving itself as more than just a gaming platform—it’s becoming a Web3 powerhouse. This versatility makes it a standout choice for those looking to diversify their crypto portfolios.

Conclusion

Qubetics, Injective, and Gala each bring something unique to the table, making them top contenders in the crypto space. Injective is revolutionizing decentralized AI development with its iAgent 2.0 launch, while Gala continues to expand its Web3 footprint through gaming and entertainment. But it’s Qubetics ($TICS) that truly stands out, bridging blockchain silos and delivering incredible ROI potential through its presale, with the next 10% price increase just around the corner. Qubetics is leading the pack among emerging cryptos to buy. Don’t miss your chance to join the Qubetics presale—this is an opportunity you don’t want to pass up!